[PPARgamma].
Itoh
Hiroshi
H
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
D017667:Adipocytes / Q000502:physiology; D000818:Animals; D015536:Down-Regulation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000502:physiology; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000502:physiology; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000209:etiology; D009154:Mutation; D009765:Obesity / Q000209:etiology; D047495:PPAR gamma / Q000819:agonists / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D018836:Inflammation Mediators; D047495:PPAR gamma; D012333:RNA, Messenger; D045162:Thiazolidinediones